Global Biosimilars Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Biosimilars market size was valued at USD 5893.3 million in 2023 and is forecast to a readjusted size of USD 17930 million by 2030 with a CAGR of 17.2% during review period.
A biosimilar is a biologic medical product highly similar to another already approved biological medicine (the 'reference medicine'). Biosimilars are approved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. Biosimilars are officially approved versions of original 'innovator' products and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Biosimilars industry chain, the market status of Oncology (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), Recombinant Glycosylated Proteins), Blood Disorders (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), Recombinant Glycosylated Proteins), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biosimilars.
Regionally, the report analyzes the Biosimilars markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biosimilars market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biosimilars market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biosimilars industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), Recombinant Glycosylated Proteins).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biosimilars market.
Regional Analysis: The report involves examining the Biosimilars market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biosimilars market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biosimilars:
Company Analysis: Report covers individual Biosimilars manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biosimilars This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Blood Disorders).
Technology Analysis: Report covers specific technologies relevant to Biosimilars. It assesses the current state, advancements, and potential future developments in Biosimilars areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biosimilars market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biosimilars market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Biosimilars product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biosimilars, with price, sales, revenue and global market share of Biosimilars from 2019 to 2024.
Chapter 3, the Biosimilars competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilars breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biosimilars.
Chapter 14 and 15, to describe Biosimilars sales channel, distributors, customers, research findings and conclusion.
A biosimilar is a biologic medical product highly similar to another already approved biological medicine (the 'reference medicine'). Biosimilars are approved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. Biosimilars are officially approved versions of original 'innovator' products and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Biosimilars industry chain, the market status of Oncology (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), Recombinant Glycosylated Proteins), Blood Disorders (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), Recombinant Glycosylated Proteins), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biosimilars.
Regionally, the report analyzes the Biosimilars markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biosimilars market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biosimilars market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biosimilars industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), Recombinant Glycosylated Proteins).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biosimilars market.
Regional Analysis: The report involves examining the Biosimilars market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biosimilars market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biosimilars:
Company Analysis: Report covers individual Biosimilars manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biosimilars This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Blood Disorders).
Technology Analysis: Report covers specific technologies relevant to Biosimilars. It assesses the current state, advancements, and potential future developments in Biosimilars areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biosimilars market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biosimilars market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
- Recombinant Glycosylated Proteins
- Oncology
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Others
- Pfizer
- Novartis
- Biocon
- Biogen
- Fresenius Kabi AG
- Boehringer Ingelheim
- Merck KgaA
- Mylan
- Eli Lilly
- Teva Pharmaceutical
- Dr. Reddy's Laboratories
- Amgen
- Celltrion
- Samsung Biologics
- Roche
- Probiomed
- Apotex
- Chong Kun Dang
- JCR Pharmaceuticals
- Gan & Lee Pharmaceuticals
- Gedeon Richter
- Biocad
- Coherus Bioscience
- Stada Arzneimittel AG
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Biosimilars product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biosimilars, with price, sales, revenue and global market share of Biosimilars from 2019 to 2024.
Chapter 3, the Biosimilars competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilars breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biosimilars.
Chapter 14 and 15, to describe Biosimilars sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biosimilars
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biosimilars Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.3.3 Recombinant Glycosylated Proteins
1.4 Market Analysis by Application
1.4.1 Overview: Global Biosimilars Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Blood Disorders
1.4.4 Growth Hormonal Deficiency
1.4.5 Chronic and Autoimmune Disorders
1.4.6 Others
1.5 Global Biosimilars Market Size & Forecast
1.5.1 Global Biosimilars Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Biosimilars Sales Quantity (2019-2030)
1.5.3 Global Biosimilars Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Biosimilars Product and Services
2.1.4 Pfizer Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Biosimilars Product and Services
2.2.4 Novartis Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments/Updates
2.3 Biocon
2.3.1 Biocon Details
2.3.2 Biocon Major Business
2.3.3 Biocon Biosimilars Product and Services
2.3.4 Biocon Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Biocon Recent Developments/Updates
2.4 Biogen
2.4.1 Biogen Details
2.4.2 Biogen Major Business
2.4.3 Biogen Biosimilars Product and Services
2.4.4 Biogen Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Biogen Recent Developments/Updates
2.5 Fresenius Kabi AG
2.5.1 Fresenius Kabi AG Details
2.5.2 Fresenius Kabi AG Major Business
2.5.3 Fresenius Kabi AG Biosimilars Product and Services
2.5.4 Fresenius Kabi AG Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Fresenius Kabi AG Recent Developments/Updates
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Biosimilars Product and Services
2.6.4 Boehringer Ingelheim Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Boehringer Ingelheim Recent Developments/Updates
2.7 Merck KgaA
2.7.1 Merck KgaA Details
2.7.2 Merck KgaA Major Business
2.7.3 Merck KgaA Biosimilars Product and Services
2.7.4 Merck KgaA Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Merck KgaA Recent Developments/Updates
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Biosimilars Product and Services
2.8.4 Mylan Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Mylan Recent Developments/Updates
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Biosimilars Product and Services
2.9.4 Eli Lilly Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eli Lilly Recent Developments/Updates
2.10 Teva Pharmaceutical
2.10.1 Teva Pharmaceutical Details
2.10.2 Teva Pharmaceutical Major Business
2.10.3 Teva Pharmaceutical Biosimilars Product and Services
2.10.4 Teva Pharmaceutical Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Teva Pharmaceutical Recent Developments/Updates
2.11 Dr. Reddy's Laboratories
2.11.1 Dr. Reddy's Laboratories Details
2.11.2 Dr. Reddy's Laboratories Major Business
2.11.3 Dr. Reddy's Laboratories Biosimilars Product and Services
2.11.4 Dr. Reddy's Laboratories Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Dr. Reddy's Laboratories Recent Developments/Updates
2.12 Amgen
2.12.1 Amgen Details
2.12.2 Amgen Major Business
2.12.3 Amgen Biosimilars Product and Services
2.12.4 Amgen Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Amgen Recent Developments/Updates
2.13 Celltrion
2.13.1 Celltrion Details
2.13.2 Celltrion Major Business
2.13.3 Celltrion Biosimilars Product and Services
2.13.4 Celltrion Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Celltrion Recent Developments/Updates
2.14 Samsung Biologics
2.14.1 Samsung Biologics Details
2.14.2 Samsung Biologics Major Business
2.14.3 Samsung Biologics Biosimilars Product and Services
2.14.4 Samsung Biologics Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Samsung Biologics Recent Developments/Updates
2.15 Roche
2.15.1 Roche Details
2.15.2 Roche Major Business
2.15.3 Roche Biosimilars Product and Services
2.15.4 Roche Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Roche Recent Developments/Updates
2.16 Probiomed
2.16.1 Probiomed Details
2.16.2 Probiomed Major Business
2.16.3 Probiomed Biosimilars Product and Services
2.16.4 Probiomed Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Probiomed Recent Developments/Updates
2.17 Apotex
2.17.1 Apotex Details
2.17.2 Apotex Major Business
2.17.3 Apotex Biosimilars Product and Services
2.17.4 Apotex Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Apotex Recent Developments/Updates
2.18 Chong Kun Dang
2.18.1 Chong Kun Dang Details
2.18.2 Chong Kun Dang Major Business
2.18.3 Chong Kun Dang Biosimilars Product and Services
2.18.4 Chong Kun Dang Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Chong Kun Dang Recent Developments/Updates
2.19 JCR Pharmaceuticals
2.19.1 JCR Pharmaceuticals Details
2.19.2 JCR Pharmaceuticals Major Business
2.19.3 JCR Pharmaceuticals Biosimilars Product and Services
2.19.4 JCR Pharmaceuticals Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 JCR Pharmaceuticals Recent Developments/Updates
2.20 Gan & Lee Pharmaceuticals
2.20.1 Gan & Lee Pharmaceuticals Details
2.20.2 Gan & Lee Pharmaceuticals Major Business
2.20.3 Gan & Lee Pharmaceuticals Biosimilars Product and Services
2.20.4 Gan & Lee Pharmaceuticals Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
2.21 Gedeon Richter
2.21.1 Gedeon Richter Details
2.21.2 Gedeon Richter Major Business
2.21.3 Gedeon Richter Biosimilars Product and Services
2.21.4 Gedeon Richter Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Gedeon Richter Recent Developments/Updates
2.22 Biocad
2.22.1 Biocad Details
2.22.2 Biocad Major Business
2.22.3 Biocad Biosimilars Product and Services
2.22.4 Biocad Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Biocad Recent Developments/Updates
2.23 Coherus Bioscience
2.23.1 Coherus Bioscience Details
2.23.2 Coherus Bioscience Major Business
2.23.3 Coherus Bioscience Biosimilars Product and Services
2.23.4 Coherus Bioscience Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 Coherus Bioscience Recent Developments/Updates
2.24 Stada Arzneimittel AG
2.24.1 Stada Arzneimittel AG Details
2.24.2 Stada Arzneimittel AG Major Business
2.24.3 Stada Arzneimittel AG Biosimilars Product and Services
2.24.4 Stada Arzneimittel AG Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.24.5 Stada Arzneimittel AG Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOSIMILARS BY MANUFACTURER
3.1 Global Biosimilars Sales Quantity by Manufacturer (2019-2024)
3.2 Global Biosimilars Revenue by Manufacturer (2019-2024)
3.3 Global Biosimilars Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Biosimilars by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Biosimilars Manufacturer Market Share in 2023
3.4.2 Top 6 Biosimilars Manufacturer Market Share in 2023
3.5 Biosimilars Market: Overall Company Footprint Analysis
3.5.1 Biosimilars Market: Region Footprint
3.5.2 Biosimilars Market: Company Product Type Footprint
3.5.3 Biosimilars Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biosimilars Market Size by Region
4.1.1 Global Biosimilars Sales Quantity by Region (2019-2030)
4.1.2 Global Biosimilars Consumption Value by Region (2019-2030)
4.1.3 Global Biosimilars Average Price by Region (2019-2030)
4.2 North America Biosimilars Consumption Value (2019-2030)
4.3 Europe Biosimilars Consumption Value (2019-2030)
4.4 Asia-Pacific Biosimilars Consumption Value (2019-2030)
4.5 South America Biosimilars Consumption Value (2019-2030)
4.6 Middle East and Africa Biosimilars Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Biosimilars Sales Quantity by Type (2019-2030)
5.2 Global Biosimilars Consumption Value by Type (2019-2030)
5.3 Global Biosimilars Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biosimilars Sales Quantity by Application (2019-2030)
6.2 Global Biosimilars Consumption Value by Application (2019-2030)
6.3 Global Biosimilars Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Biosimilars Sales Quantity by Type (2019-2030)
7.2 North America Biosimilars Sales Quantity by Application (2019-2030)
7.3 North America Biosimilars Market Size by Country
7.3.1 North America Biosimilars Sales Quantity by Country (2019-2030)
7.3.2 North America Biosimilars Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Biosimilars Sales Quantity by Type (2019-2030)
8.2 Europe Biosimilars Sales Quantity by Application (2019-2030)
8.3 Europe Biosimilars Market Size by Country
8.3.1 Europe Biosimilars Sales Quantity by Country (2019-2030)
8.3.2 Europe Biosimilars Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biosimilars Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Biosimilars Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Biosimilars Market Size by Region
9.3.1 Asia-Pacific Biosimilars Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Biosimilars Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Biosimilars Sales Quantity by Type (2019-2030)
10.2 South America Biosimilars Sales Quantity by Application (2019-2030)
10.3 South America Biosimilars Market Size by Country
10.3.1 South America Biosimilars Sales Quantity by Country (2019-2030)
10.3.2 South America Biosimilars Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biosimilars Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Biosimilars Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Biosimilars Market Size by Country
11.3.1 Middle East & Africa Biosimilars Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Biosimilars Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Biosimilars Market Drivers
12.2 Biosimilars Market Restraints
12.3 Biosimilars Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biosimilars and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biosimilars
13.3 Biosimilars Production Process
13.4 Biosimilars Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biosimilars Typical Distributors
14.3 Biosimilars Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Biosimilars
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biosimilars Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.3.3 Recombinant Glycosylated Proteins
1.4 Market Analysis by Application
1.4.1 Overview: Global Biosimilars Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Blood Disorders
1.4.4 Growth Hormonal Deficiency
1.4.5 Chronic and Autoimmune Disorders
1.4.6 Others
1.5 Global Biosimilars Market Size & Forecast
1.5.1 Global Biosimilars Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Biosimilars Sales Quantity (2019-2030)
1.5.3 Global Biosimilars Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Biosimilars Product and Services
2.1.4 Pfizer Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Biosimilars Product and Services
2.2.4 Novartis Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments/Updates
2.3 Biocon
2.3.1 Biocon Details
2.3.2 Biocon Major Business
2.3.3 Biocon Biosimilars Product and Services
2.3.4 Biocon Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Biocon Recent Developments/Updates
2.4 Biogen
2.4.1 Biogen Details
2.4.2 Biogen Major Business
2.4.3 Biogen Biosimilars Product and Services
2.4.4 Biogen Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Biogen Recent Developments/Updates
2.5 Fresenius Kabi AG
2.5.1 Fresenius Kabi AG Details
2.5.2 Fresenius Kabi AG Major Business
2.5.3 Fresenius Kabi AG Biosimilars Product and Services
2.5.4 Fresenius Kabi AG Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Fresenius Kabi AG Recent Developments/Updates
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Biosimilars Product and Services
2.6.4 Boehringer Ingelheim Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Boehringer Ingelheim Recent Developments/Updates
2.7 Merck KgaA
2.7.1 Merck KgaA Details
2.7.2 Merck KgaA Major Business
2.7.3 Merck KgaA Biosimilars Product and Services
2.7.4 Merck KgaA Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Merck KgaA Recent Developments/Updates
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Biosimilars Product and Services
2.8.4 Mylan Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Mylan Recent Developments/Updates
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Biosimilars Product and Services
2.9.4 Eli Lilly Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eli Lilly Recent Developments/Updates
2.10 Teva Pharmaceutical
2.10.1 Teva Pharmaceutical Details
2.10.2 Teva Pharmaceutical Major Business
2.10.3 Teva Pharmaceutical Biosimilars Product and Services
2.10.4 Teva Pharmaceutical Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Teva Pharmaceutical Recent Developments/Updates
2.11 Dr. Reddy's Laboratories
2.11.1 Dr. Reddy's Laboratories Details
2.11.2 Dr. Reddy's Laboratories Major Business
2.11.3 Dr. Reddy's Laboratories Biosimilars Product and Services
2.11.4 Dr. Reddy's Laboratories Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Dr. Reddy's Laboratories Recent Developments/Updates
2.12 Amgen
2.12.1 Amgen Details
2.12.2 Amgen Major Business
2.12.3 Amgen Biosimilars Product and Services
2.12.4 Amgen Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Amgen Recent Developments/Updates
2.13 Celltrion
2.13.1 Celltrion Details
2.13.2 Celltrion Major Business
2.13.3 Celltrion Biosimilars Product and Services
2.13.4 Celltrion Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Celltrion Recent Developments/Updates
2.14 Samsung Biologics
2.14.1 Samsung Biologics Details
2.14.2 Samsung Biologics Major Business
2.14.3 Samsung Biologics Biosimilars Product and Services
2.14.4 Samsung Biologics Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Samsung Biologics Recent Developments/Updates
2.15 Roche
2.15.1 Roche Details
2.15.2 Roche Major Business
2.15.3 Roche Biosimilars Product and Services
2.15.4 Roche Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Roche Recent Developments/Updates
2.16 Probiomed
2.16.1 Probiomed Details
2.16.2 Probiomed Major Business
2.16.3 Probiomed Biosimilars Product and Services
2.16.4 Probiomed Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Probiomed Recent Developments/Updates
2.17 Apotex
2.17.1 Apotex Details
2.17.2 Apotex Major Business
2.17.3 Apotex Biosimilars Product and Services
2.17.4 Apotex Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Apotex Recent Developments/Updates
2.18 Chong Kun Dang
2.18.1 Chong Kun Dang Details
2.18.2 Chong Kun Dang Major Business
2.18.3 Chong Kun Dang Biosimilars Product and Services
2.18.4 Chong Kun Dang Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Chong Kun Dang Recent Developments/Updates
2.19 JCR Pharmaceuticals
2.19.1 JCR Pharmaceuticals Details
2.19.2 JCR Pharmaceuticals Major Business
2.19.3 JCR Pharmaceuticals Biosimilars Product and Services
2.19.4 JCR Pharmaceuticals Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 JCR Pharmaceuticals Recent Developments/Updates
2.20 Gan & Lee Pharmaceuticals
2.20.1 Gan & Lee Pharmaceuticals Details
2.20.2 Gan & Lee Pharmaceuticals Major Business
2.20.3 Gan & Lee Pharmaceuticals Biosimilars Product and Services
2.20.4 Gan & Lee Pharmaceuticals Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
2.21 Gedeon Richter
2.21.1 Gedeon Richter Details
2.21.2 Gedeon Richter Major Business
2.21.3 Gedeon Richter Biosimilars Product and Services
2.21.4 Gedeon Richter Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Gedeon Richter Recent Developments/Updates
2.22 Biocad
2.22.1 Biocad Details
2.22.2 Biocad Major Business
2.22.3 Biocad Biosimilars Product and Services
2.22.4 Biocad Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Biocad Recent Developments/Updates
2.23 Coherus Bioscience
2.23.1 Coherus Bioscience Details
2.23.2 Coherus Bioscience Major Business
2.23.3 Coherus Bioscience Biosimilars Product and Services
2.23.4 Coherus Bioscience Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 Coherus Bioscience Recent Developments/Updates
2.24 Stada Arzneimittel AG
2.24.1 Stada Arzneimittel AG Details
2.24.2 Stada Arzneimittel AG Major Business
2.24.3 Stada Arzneimittel AG Biosimilars Product and Services
2.24.4 Stada Arzneimittel AG Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.24.5 Stada Arzneimittel AG Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOSIMILARS BY MANUFACTURER
3.1 Global Biosimilars Sales Quantity by Manufacturer (2019-2024)
3.2 Global Biosimilars Revenue by Manufacturer (2019-2024)
3.3 Global Biosimilars Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Biosimilars by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Biosimilars Manufacturer Market Share in 2023
3.4.2 Top 6 Biosimilars Manufacturer Market Share in 2023
3.5 Biosimilars Market: Overall Company Footprint Analysis
3.5.1 Biosimilars Market: Region Footprint
3.5.2 Biosimilars Market: Company Product Type Footprint
3.5.3 Biosimilars Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biosimilars Market Size by Region
4.1.1 Global Biosimilars Sales Quantity by Region (2019-2030)
4.1.2 Global Biosimilars Consumption Value by Region (2019-2030)
4.1.3 Global Biosimilars Average Price by Region (2019-2030)
4.2 North America Biosimilars Consumption Value (2019-2030)
4.3 Europe Biosimilars Consumption Value (2019-2030)
4.4 Asia-Pacific Biosimilars Consumption Value (2019-2030)
4.5 South America Biosimilars Consumption Value (2019-2030)
4.6 Middle East and Africa Biosimilars Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Biosimilars Sales Quantity by Type (2019-2030)
5.2 Global Biosimilars Consumption Value by Type (2019-2030)
5.3 Global Biosimilars Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biosimilars Sales Quantity by Application (2019-2030)
6.2 Global Biosimilars Consumption Value by Application (2019-2030)
6.3 Global Biosimilars Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Biosimilars Sales Quantity by Type (2019-2030)
7.2 North America Biosimilars Sales Quantity by Application (2019-2030)
7.3 North America Biosimilars Market Size by Country
7.3.1 North America Biosimilars Sales Quantity by Country (2019-2030)
7.3.2 North America Biosimilars Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Biosimilars Sales Quantity by Type (2019-2030)
8.2 Europe Biosimilars Sales Quantity by Application (2019-2030)
8.3 Europe Biosimilars Market Size by Country
8.3.1 Europe Biosimilars Sales Quantity by Country (2019-2030)
8.3.2 Europe Biosimilars Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biosimilars Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Biosimilars Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Biosimilars Market Size by Region
9.3.1 Asia-Pacific Biosimilars Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Biosimilars Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Biosimilars Sales Quantity by Type (2019-2030)
10.2 South America Biosimilars Sales Quantity by Application (2019-2030)
10.3 South America Biosimilars Market Size by Country
10.3.1 South America Biosimilars Sales Quantity by Country (2019-2030)
10.3.2 South America Biosimilars Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biosimilars Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Biosimilars Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Biosimilars Market Size by Country
11.3.1 Middle East & Africa Biosimilars Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Biosimilars Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Biosimilars Market Drivers
12.2 Biosimilars Market Restraints
12.3 Biosimilars Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biosimilars and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biosimilars
13.3 Biosimilars Production Process
13.4 Biosimilars Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biosimilars Typical Distributors
14.3 Biosimilars Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Biosimilars Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biosimilars Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Biosimilars Product and Services
Table 6. Pfizer Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Major Business
Table 10. Novartis Biosimilars Product and Services
Table 11. Novartis Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Novartis Recent Developments/Updates
Table 13. Biocon Basic Information, Manufacturing Base and Competitors
Table 14. Biocon Major Business
Table 15. Biocon Biosimilars Product and Services
Table 16. Biocon Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Biocon Recent Developments/Updates
Table 18. Biogen Basic Information, Manufacturing Base and Competitors
Table 19. Biogen Major Business
Table 20. Biogen Biosimilars Product and Services
Table 21. Biogen Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Biogen Recent Developments/Updates
Table 23. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 24. Fresenius Kabi AG Major Business
Table 25. Fresenius Kabi AG Biosimilars Product and Services
Table 26. Fresenius Kabi AG Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Fresenius Kabi AG Recent Developments/Updates
Table 28. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 29. Boehringer Ingelheim Major Business
Table 30. Boehringer Ingelheim Biosimilars Product and Services
Table 31. Boehringer Ingelheim Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Boehringer Ingelheim Recent Developments/Updates
Table 33. Merck KgaA Basic Information, Manufacturing Base and Competitors
Table 34. Merck KgaA Major Business
Table 35. Merck KgaA Biosimilars Product and Services
Table 36. Merck KgaA Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Merck KgaA Recent Developments/Updates
Table 38. Mylan Basic Information, Manufacturing Base and Competitors
Table 39. Mylan Major Business
Table 40. Mylan Biosimilars Product and Services
Table 41. Mylan Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Mylan Recent Developments/Updates
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly Biosimilars Product and Services
Table 46. Eli Lilly Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Eli Lilly Recent Developments/Updates
Table 48. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Teva Pharmaceutical Major Business
Table 50. Teva Pharmaceutical Biosimilars Product and Services
Table 51. Teva Pharmaceutical Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Teva Pharmaceutical Recent Developments/Updates
Table 53. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 54. Dr. Reddy's Laboratories Major Business
Table 55. Dr. Reddy's Laboratories Biosimilars Product and Services
Table 56. Dr. Reddy's Laboratories Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Dr. Reddy's Laboratories Recent Developments/Updates
Table 58. Amgen Basic Information, Manufacturing Base and Competitors
Table 59. Amgen Major Business
Table 60. Amgen Biosimilars Product and Services
Table 61. Amgen Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Amgen Recent Developments/Updates
Table 63. Celltrion Basic Information, Manufacturing Base and Competitors
Table 64. Celltrion Major Business
Table 65. Celltrion Biosimilars Product and Services
Table 66. Celltrion Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Celltrion Recent Developments/Updates
Table 68. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 69. Samsung Biologics Major Business
Table 70. Samsung Biologics Biosimilars Product and Services
Table 71. Samsung Biologics Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Samsung Biologics Recent Developments/Updates
Table 73. Roche Basic Information, Manufacturing Base and Competitors
Table 74. Roche Major Business
Table 75. Roche Biosimilars Product and Services
Table 76. Roche Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Roche Recent Developments/Updates
Table 78. Probiomed Basic Information, Manufacturing Base and Competitors
Table 79. Probiomed Major Business
Table 80. Probiomed Biosimilars Product and Services
Table 81. Probiomed Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Probiomed Recent Developments/Updates
Table 83. Apotex Basic Information, Manufacturing Base and Competitors
Table 84. Apotex Major Business
Table 85. Apotex Biosimilars Product and Services
Table 86. Apotex Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Apotex Recent Developments/Updates
Table 88. Chong Kun Dang Basic Information, Manufacturing Base and Competitors
Table 89. Chong Kun Dang Major Business
Table 90. Chong Kun Dang Biosimilars Product and Services
Table 91. Chong Kun Dang Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Chong Kun Dang Recent Developments/Updates
Table 93. JCR Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 94. JCR Pharmaceuticals Major Business
Table 95. JCR Pharmaceuticals Biosimilars Product and Services
Table 96. JCR Pharmaceuticals Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. JCR Pharmaceuticals Recent Developments/Updates
Table 98. Gan & Lee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 99. Gan & Lee Pharmaceuticals Major Business
Table 100. Gan & Lee Pharmaceuticals Biosimilars Product and Services
Table 101. Gan & Lee Pharmaceuticals Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 103. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 104. Gedeon Richter Major Business
Table 105. Gedeon Richter Biosimilars Product and Services
Table 106. Gedeon Richter Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Gedeon Richter Recent Developments/Updates
Table 108. Biocad Basic Information, Manufacturing Base and Competitors
Table 109. Biocad Major Business
Table 110. Biocad Biosimilars Product and Services
Table 111. Biocad Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Biocad Recent Developments/Updates
Table 113. Coherus Bioscience Basic Information, Manufacturing Base and Competitors
Table 114. Coherus Bioscience Major Business
Table 115. Coherus Bioscience Biosimilars Product and Services
Table 116. Coherus Bioscience Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 117. Coherus Bioscience Recent Developments/Updates
Table 118. Stada Arzneimittel AG Basic Information, Manufacturing Base and Competitors
Table 119. Stada Arzneimittel AG Major Business
Table 120. Stada Arzneimittel AG Biosimilars Product and Services
Table 121. Stada Arzneimittel AG Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 122. Stada Arzneimittel AG Recent Developments/Updates
Table 123. Global Biosimilars Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 124. Global Biosimilars Revenue by Manufacturer (2019-2024) & (USD Million)
Table 125. Global Biosimilars Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 126. Market Position of Manufacturers in Biosimilars, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 127. Head Office and Biosimilars Production Site of Key Manufacturer
Table 128. Biosimilars Market: Company Product Type Footprint
Table 129. Biosimilars Market: Company Product Application Footprint
Table 130. Biosimilars New Market Entrants and Barriers to Market Entry
Table 131. Biosimilars Mergers, Acquisition, Agreements, and Collaborations
Table 132. Global Biosimilars Sales Quantity by Region (2019-2024) & (K Units)
Table 133. Global Biosimilars Sales Quantity by Region (2025-2030) & (K Units)
Table 134. Global Biosimilars Consumption Value by Region (2019-2024) & (USD Million)
Table 135. Global Biosimilars Consumption Value by Region (2025-2030) & (USD Million)
Table 136. Global Biosimilars Average Price by Region (2019-2024) & (USD/Unit)
Table 137. Global Biosimilars Average Price by Region (2025-2030) & (USD/Unit)
Table 138. Global Biosimilars Sales Quantity by Type (2019-2024) & (K Units)
Table 139. Global Biosimilars Sales Quantity by Type (2025-2030) & (K Units)
Table 140. Global Biosimilars Consumption Value by Type (2019-2024) & (USD Million)
Table 141. Global Biosimilars Consumption Value by Type (2025-2030) & (USD Million)
Table 142. Global Biosimilars Average Price by Type (2019-2024) & (USD/Unit)
Table 143. Global Biosimilars Average Price by Type (2025-2030) & (USD/Unit)
Table 144. Global Biosimilars Sales Quantity by Application (2019-2024) & (K Units)
Table 145. Global Biosimilars Sales Quantity by Application (2025-2030) & (K Units)
Table 146. Global Biosimilars Consumption Value by Application (2019-2024) & (USD Million)
Table 147. Global Biosimilars Consumption Value by Application (2025-2030) & (USD Million)
Table 148. Global Biosimilars Average Price by Application (2019-2024) & (USD/Unit)
Table 149. Global Biosimilars Average Price by Application (2025-2030) & (USD/Unit)
Table 150. North America Biosimilars Sales Quantity by Type (2019-2024) & (K Units)
Table 151. North America Biosimilars Sales Quantity by Type (2025-2030) & (K Units)
Table 152. North America Biosimilars Sales Quantity by Application (2019-2024) & (K Units)
Table 153. North America Biosimilars Sales Quantity by Application (2025-2030) & (K Units)
Table 154. North America Biosimilars Sales Quantity by Country (2019-2024) & (K Units)
Table 155. North America Biosimilars Sales Quantity by Country (2025-2030) & (K Units)
Table 156. North America Biosimilars Consumption Value by Country (2019-2024) & (USD Million)
Table 157. North America Biosimilars Consumption Value by Country (2025-2030) & (USD Million)
Table 158. Europe Biosimilars Sales Quantity by Type (2019-2024) & (K Units)
Table 159. Europe Biosimilars Sales Quantity by Type (2025-2030) & (K Units)
Table 160. Europe Biosimilars Sales Quantity by Application (2019-2024) & (K Units)
Table 161. Europe Biosimilars Sales Quantity by Application (2025-2030) & (K Units)
Table 162. Europe Biosimilars Sales Quantity by Country (2019-2024) & (K Units)
Table 163. Europe Biosimilars Sales Quantity by Country (2025-2030) & (K Units)
Table 164. Europe Biosimilars Consumption Value by Country (2019-2024) & (USD Million)
Table 165. Europe Biosimilars Consumption Value by Country (2025-2030) & (USD Million)
Table 166. Asia-Pacific Biosimilars Sales Quantity by Type (2019-2024) & (K Units)
Table 167. Asia-Pacific Biosimilars Sales Quantity by Type (2025-2030) & (K Units)
Table 168. Asia-Pacific Biosimilars Sales Quantity by Application (2019-2024) & (K Units)
Table 169. Asia-Pacific Biosimilars Sales Quantity by Application (2025-2030) & (K Units)
Table 170. Asia-Pacific Biosimilars Sales Quantity by Region (2019-2024) & (K Units)
Table 171. Asia-Pacific Biosimilars Sales Quantity by Region (2025-2030) & (K Units)
Table 172. Asia-Pacific Biosimilars Consumption Value by Region (2019-2024) & (USD Million)
Table 173. Asia-Pacific Biosimilars Consumption Value by Region (2025-2030) & (USD Million)
Table 174. South America Biosimilars Sales Quantity by Type (2019-2024) & (K Units)
Table 175. South America Biosimilars Sales Quantity by Type (2025-2030) & (K Units)
Table 176. South America Biosimilars Sales Quantity by Application (2019-2024) & (K Units)
Table 177. South America Biosimilars Sales Quantity by Application (2025-2030) & (K Units)
Table 178. South America Biosimilars Sales Quantity by Country (2019-2024) & (K Units)
Table 179. South America Biosimilars Sales Quantity by Country (2025-2030) & (K Units)
Table 180. South America Biosimilars Consumption Value by Country (2019-2024) & (USD Million)
Table 181. South America Biosimilars Consumption Value by Country (2025-2030) & (USD Million)
Table 182. Middle East & Africa Biosimilars Sales Quantity by Type (2019-2024) & (K Units)
Table 183. Middle East & Africa Biosimilars Sales Quantity by Type (2025-2030) & (K Units)
Table 184. Middle East & Africa Biosimilars Sales Quantity by Application (2019-2024) & (K Units)
Table 185. Middle East & Africa Biosimilars Sales Quantity by Application (2025-2030) & (K Units)
Table 186. Middle East & Africa Biosimilars Sales Quantity by Region (2019-2024) & (K Units)
Table 187. Middle East & Africa Biosimilars Sales Quantity by Region (2025-2030) & (K Units)
Table 188. Middle East & Africa Biosimilars Consumption Value by Region (2019-2024) & (USD Million)
Table 189. Middle East & Africa Biosimilars Consumption Value by Region (2025-2030) & (USD Million)
Table 190. Biosimilars Raw Material
Table 191. Key Manufacturers of Biosimilars Raw Materials
Table 192. Biosimilars Typical Distributors
Table 193. Biosimilars Typical Customers
Table 1. Global Biosimilars Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biosimilars Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Biosimilars Product and Services
Table 6. Pfizer Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Major Business
Table 10. Novartis Biosimilars Product and Services
Table 11. Novartis Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Novartis Recent Developments/Updates
Table 13. Biocon Basic Information, Manufacturing Base and Competitors
Table 14. Biocon Major Business
Table 15. Biocon Biosimilars Product and Services
Table 16. Biocon Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Biocon Recent Developments/Updates
Table 18. Biogen Basic Information, Manufacturing Base and Competitors
Table 19. Biogen Major Business
Table 20. Biogen Biosimilars Product and Services
Table 21. Biogen Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Biogen Recent Developments/Updates
Table 23. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 24. Fresenius Kabi AG Major Business
Table 25. Fresenius Kabi AG Biosimilars Product and Services
Table 26. Fresenius Kabi AG Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Fresenius Kabi AG Recent Developments/Updates
Table 28. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 29. Boehringer Ingelheim Major Business
Table 30. Boehringer Ingelheim Biosimilars Product and Services
Table 31. Boehringer Ingelheim Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Boehringer Ingelheim Recent Developments/Updates
Table 33. Merck KgaA Basic Information, Manufacturing Base and Competitors
Table 34. Merck KgaA Major Business
Table 35. Merck KgaA Biosimilars Product and Services
Table 36. Merck KgaA Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Merck KgaA Recent Developments/Updates
Table 38. Mylan Basic Information, Manufacturing Base and Competitors
Table 39. Mylan Major Business
Table 40. Mylan Biosimilars Product and Services
Table 41. Mylan Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Mylan Recent Developments/Updates
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly Biosimilars Product and Services
Table 46. Eli Lilly Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Eli Lilly Recent Developments/Updates
Table 48. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Teva Pharmaceutical Major Business
Table 50. Teva Pharmaceutical Biosimilars Product and Services
Table 51. Teva Pharmaceutical Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Teva Pharmaceutical Recent Developments/Updates
Table 53. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 54. Dr. Reddy's Laboratories Major Business
Table 55. Dr. Reddy's Laboratories Biosimilars Product and Services
Table 56. Dr. Reddy's Laboratories Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Dr. Reddy's Laboratories Recent Developments/Updates
Table 58. Amgen Basic Information, Manufacturing Base and Competitors
Table 59. Amgen Major Business
Table 60. Amgen Biosimilars Product and Services
Table 61. Amgen Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Amgen Recent Developments/Updates
Table 63. Celltrion Basic Information, Manufacturing Base and Competitors
Table 64. Celltrion Major Business
Table 65. Celltrion Biosimilars Product and Services
Table 66. Celltrion Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Celltrion Recent Developments/Updates
Table 68. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 69. Samsung Biologics Major Business
Table 70. Samsung Biologics Biosimilars Product and Services
Table 71. Samsung Biologics Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Samsung Biologics Recent Developments/Updates
Table 73. Roche Basic Information, Manufacturing Base and Competitors
Table 74. Roche Major Business
Table 75. Roche Biosimilars Product and Services
Table 76. Roche Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Roche Recent Developments/Updates
Table 78. Probiomed Basic Information, Manufacturing Base and Competitors
Table 79. Probiomed Major Business
Table 80. Probiomed Biosimilars Product and Services
Table 81. Probiomed Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Probiomed Recent Developments/Updates
Table 83. Apotex Basic Information, Manufacturing Base and Competitors
Table 84. Apotex Major Business
Table 85. Apotex Biosimilars Product and Services
Table 86. Apotex Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Apotex Recent Developments/Updates
Table 88. Chong Kun Dang Basic Information, Manufacturing Base and Competitors
Table 89. Chong Kun Dang Major Business
Table 90. Chong Kun Dang Biosimilars Product and Services
Table 91. Chong Kun Dang Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Chong Kun Dang Recent Developments/Updates
Table 93. JCR Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 94. JCR Pharmaceuticals Major Business
Table 95. JCR Pharmaceuticals Biosimilars Product and Services
Table 96. JCR Pharmaceuticals Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. JCR Pharmaceuticals Recent Developments/Updates
Table 98. Gan & Lee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 99. Gan & Lee Pharmaceuticals Major Business
Table 100. Gan & Lee Pharmaceuticals Biosimilars Product and Services
Table 101. Gan & Lee Pharmaceuticals Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 103. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 104. Gedeon Richter Major Business
Table 105. Gedeon Richter Biosimilars Product and Services
Table 106. Gedeon Richter Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Gedeon Richter Recent Developments/Updates
Table 108. Biocad Basic Information, Manufacturing Base and Competitors
Table 109. Biocad Major Business
Table 110. Biocad Biosimilars Product and Services
Table 111. Biocad Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Biocad Recent Developments/Updates
Table 113. Coherus Bioscience Basic Information, Manufacturing Base and Competitors
Table 114. Coherus Bioscience Major Business
Table 115. Coherus Bioscience Biosimilars Product and Services
Table 116. Coherus Bioscience Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 117. Coherus Bioscience Recent Developments/Updates
Table 118. Stada Arzneimittel AG Basic Information, Manufacturing Base and Competitors
Table 119. Stada Arzneimittel AG Major Business
Table 120. Stada Arzneimittel AG Biosimilars Product and Services
Table 121. Stada Arzneimittel AG Biosimilars Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 122. Stada Arzneimittel AG Recent Developments/Updates
Table 123. Global Biosimilars Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 124. Global Biosimilars Revenue by Manufacturer (2019-2024) & (USD Million)
Table 125. Global Biosimilars Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 126. Market Position of Manufacturers in Biosimilars, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 127. Head Office and Biosimilars Production Site of Key Manufacturer
Table 128. Biosimilars Market: Company Product Type Footprint
Table 129. Biosimilars Market: Company Product Application Footprint
Table 130. Biosimilars New Market Entrants and Barriers to Market Entry
Table 131. Biosimilars Mergers, Acquisition, Agreements, and Collaborations
Table 132. Global Biosimilars Sales Quantity by Region (2019-2024) & (K Units)
Table 133. Global Biosimilars Sales Quantity by Region (2025-2030) & (K Units)
Table 134. Global Biosimilars Consumption Value by Region (2019-2024) & (USD Million)
Table 135. Global Biosimilars Consumption Value by Region (2025-2030) & (USD Million)
Table 136. Global Biosimilars Average Price by Region (2019-2024) & (USD/Unit)
Table 137. Global Biosimilars Average Price by Region (2025-2030) & (USD/Unit)
Table 138. Global Biosimilars Sales Quantity by Type (2019-2024) & (K Units)
Table 139. Global Biosimilars Sales Quantity by Type (2025-2030) & (K Units)
Table 140. Global Biosimilars Consumption Value by Type (2019-2024) & (USD Million)
Table 141. Global Biosimilars Consumption Value by Type (2025-2030) & (USD Million)
Table 142. Global Biosimilars Average Price by Type (2019-2024) & (USD/Unit)
Table 143. Global Biosimilars Average Price by Type (2025-2030) & (USD/Unit)
Table 144. Global Biosimilars Sales Quantity by Application (2019-2024) & (K Units)
Table 145. Global Biosimilars Sales Quantity by Application (2025-2030) & (K Units)
Table 146. Global Biosimilars Consumption Value by Application (2019-2024) & (USD Million)
Table 147. Global Biosimilars Consumption Value by Application (2025-2030) & (USD Million)
Table 148. Global Biosimilars Average Price by Application (2019-2024) & (USD/Unit)
Table 149. Global Biosimilars Average Price by Application (2025-2030) & (USD/Unit)
Table 150. North America Biosimilars Sales Quantity by Type (2019-2024) & (K Units)
Table 151. North America Biosimilars Sales Quantity by Type (2025-2030) & (K Units)
Table 152. North America Biosimilars Sales Quantity by Application (2019-2024) & (K Units)
Table 153. North America Biosimilars Sales Quantity by Application (2025-2030) & (K Units)
Table 154. North America Biosimilars Sales Quantity by Country (2019-2024) & (K Units)
Table 155. North America Biosimilars Sales Quantity by Country (2025-2030) & (K Units)
Table 156. North America Biosimilars Consumption Value by Country (2019-2024) & (USD Million)
Table 157. North America Biosimilars Consumption Value by Country (2025-2030) & (USD Million)
Table 158. Europe Biosimilars Sales Quantity by Type (2019-2024) & (K Units)
Table 159. Europe Biosimilars Sales Quantity by Type (2025-2030) & (K Units)
Table 160. Europe Biosimilars Sales Quantity by Application (2019-2024) & (K Units)
Table 161. Europe Biosimilars Sales Quantity by Application (2025-2030) & (K Units)
Table 162. Europe Biosimilars Sales Quantity by Country (2019-2024) & (K Units)
Table 163. Europe Biosimilars Sales Quantity by Country (2025-2030) & (K Units)
Table 164. Europe Biosimilars Consumption Value by Country (2019-2024) & (USD Million)
Table 165. Europe Biosimilars Consumption Value by Country (2025-2030) & (USD Million)
Table 166. Asia-Pacific Biosimilars Sales Quantity by Type (2019-2024) & (K Units)
Table 167. Asia-Pacific Biosimilars Sales Quantity by Type (2025-2030) & (K Units)
Table 168. Asia-Pacific Biosimilars Sales Quantity by Application (2019-2024) & (K Units)
Table 169. Asia-Pacific Biosimilars Sales Quantity by Application (2025-2030) & (K Units)
Table 170. Asia-Pacific Biosimilars Sales Quantity by Region (2019-2024) & (K Units)
Table 171. Asia-Pacific Biosimilars Sales Quantity by Region (2025-2030) & (K Units)
Table 172. Asia-Pacific Biosimilars Consumption Value by Region (2019-2024) & (USD Million)
Table 173. Asia-Pacific Biosimilars Consumption Value by Region (2025-2030) & (USD Million)
Table 174. South America Biosimilars Sales Quantity by Type (2019-2024) & (K Units)
Table 175. South America Biosimilars Sales Quantity by Type (2025-2030) & (K Units)
Table 176. South America Biosimilars Sales Quantity by Application (2019-2024) & (K Units)
Table 177. South America Biosimilars Sales Quantity by Application (2025-2030) & (K Units)
Table 178. South America Biosimilars Sales Quantity by Country (2019-2024) & (K Units)
Table 179. South America Biosimilars Sales Quantity by Country (2025-2030) & (K Units)
Table 180. South America Biosimilars Consumption Value by Country (2019-2024) & (USD Million)
Table 181. South America Biosimilars Consumption Value by Country (2025-2030) & (USD Million)
Table 182. Middle East & Africa Biosimilars Sales Quantity by Type (2019-2024) & (K Units)
Table 183. Middle East & Africa Biosimilars Sales Quantity by Type (2025-2030) & (K Units)
Table 184. Middle East & Africa Biosimilars Sales Quantity by Application (2019-2024) & (K Units)
Table 185. Middle East & Africa Biosimilars Sales Quantity by Application (2025-2030) & (K Units)
Table 186. Middle East & Africa Biosimilars Sales Quantity by Region (2019-2024) & (K Units)
Table 187. Middle East & Africa Biosimilars Sales Quantity by Region (2025-2030) & (K Units)
Table 188. Middle East & Africa Biosimilars Consumption Value by Region (2019-2024) & (USD Million)
Table 189. Middle East & Africa Biosimilars Consumption Value by Region (2025-2030) & (USD Million)
Table 190. Biosimilars Raw Material
Table 191. Key Manufacturers of Biosimilars Raw Materials
Table 192. Biosimilars Typical Distributors
Table 193. Biosimilars Typical Customers
LIST OF FIGURES
Figure 1. Biosimilars Picture
Figure 2. Global Biosimilars Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biosimilars Consumption Value Market Share by Type in 2023
Figure 4. Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Examples
Figure 5. Recombinant Glycosylated Proteins Examples
Figure 6. Global Biosimilars Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Biosimilars Consumption Value Market Share by Application in 2023
Figure 8. Oncology Examples
Figure 9. Blood Disorders Examples
Figure 10. Growth Hormonal Deficiency Examples
Figure 11. Chronic and Autoimmune Disorders Examples
Figure 12. Others Examples
Figure 13. Global Biosimilars Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Biosimilars Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Biosimilars Sales Quantity (2019-2030) & (K Units)
Figure 16. Global Biosimilars Average Price (2019-2030) & (USD/Unit)
Figure 17. Global Biosimilars Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Biosimilars Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Biosimilars by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Biosimilars Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Biosimilars Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Biosimilars Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Biosimilars Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Biosimilars Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Biosimilars Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Biosimilars Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Biosimilars Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Biosimilars Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Biosimilars Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Biosimilars Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Biosimilars Average Price by Type (2019-2030) & (USD/Unit)
Figure 32. Global Biosimilars Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Biosimilars Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Biosimilars Average Price by Application (2019-2030) & (USD/Unit)
Figure 35. North America Biosimilars Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Biosimilars Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Biosimilars Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Biosimilars Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Biosimilars Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Biosimilars Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Biosimilars Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Biosimilars Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Biosimilars Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Biosimilars Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Biosimilars Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Biosimilars Consumption Value Market Share by Region (2019-2030)
Figure 55. China Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Biosimilars Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Biosimilars Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Biosimilars Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Biosimilars Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Biosimilars Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Biosimilars Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Biosimilars Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Biosimilars Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Biosimilars Market Drivers
Figure 76. Biosimilars Market Restraints
Figure 77. Biosimilars Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Biosimilars in 2023
Figure 80. Manufacturing Process Analysis of Biosimilars
Figure 81. Biosimilars Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Biosimilars Picture
Figure 2. Global Biosimilars Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biosimilars Consumption Value Market Share by Type in 2023
Figure 4. Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Examples
Figure 5. Recombinant Glycosylated Proteins Examples
Figure 6. Global Biosimilars Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Biosimilars Consumption Value Market Share by Application in 2023
Figure 8. Oncology Examples
Figure 9. Blood Disorders Examples
Figure 10. Growth Hormonal Deficiency Examples
Figure 11. Chronic and Autoimmune Disorders Examples
Figure 12. Others Examples
Figure 13. Global Biosimilars Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Biosimilars Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Biosimilars Sales Quantity (2019-2030) & (K Units)
Figure 16. Global Biosimilars Average Price (2019-2030) & (USD/Unit)
Figure 17. Global Biosimilars Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Biosimilars Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Biosimilars by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Biosimilars Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Biosimilars Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Biosimilars Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Biosimilars Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Biosimilars Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Biosimilars Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Biosimilars Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Biosimilars Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Biosimilars Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Biosimilars Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Biosimilars Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Biosimilars Average Price by Type (2019-2030) & (USD/Unit)
Figure 32. Global Biosimilars Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Biosimilars Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Biosimilars Average Price by Application (2019-2030) & (USD/Unit)
Figure 35. North America Biosimilars Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Biosimilars Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Biosimilars Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Biosimilars Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Biosimilars Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Biosimilars Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Biosimilars Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Biosimilars Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Biosimilars Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Biosimilars Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Biosimilars Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Biosimilars Consumption Value Market Share by Region (2019-2030)
Figure 55. China Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Biosimilars Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Biosimilars Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Biosimilars Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Biosimilars Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Biosimilars Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Biosimilars Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Biosimilars Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Biosimilars Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Biosimilars Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Biosimilars Market Drivers
Figure 76. Biosimilars Market Restraints
Figure 77. Biosimilars Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Biosimilars in 2023
Figure 80. Manufacturing Process Analysis of Biosimilars
Figure 81. Biosimilars Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
